Envestnet Asset Management »

Avadel Pharmaceuticals shares owned by Envestnet Asset Management

Quarter-by-quarter ownership of Avadel Pharmaceuticals (AVDL) shares owned by Envestnet Asset Management from 13F filings

Historical chart of Envestnet Asset Management investment in Avadel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Avadel Pharmaceuticals held by Envestnet Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avadel Pharmaceuticals by Envestnet Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $207k 14k 15.27
2025-06-30 $144k 16k 8.85
2025-03-31 $225k 29k 7.83
2024-12-31 $292k 28k 10.51
2024-09-30 $793k 60k 13.12
2024-06-30 $888k 63k 14.06

More positions owned by Envestnet Asset Management

Ishares Tr Core S&p500 Etf (IVV)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ishares Tr Core Total Usd (IUSB)
Microsoft Corporation (MSFT)
Ishares Tr S&p 500 Grwt Etf (IVW)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Core Msci Emkt (IEMG)
Ishares Tr S&p 500 Val Etf (IVE)
NVIDIA Corporation (NVDA)
Ishares Tr Eafe Value Etf (EFV)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr S&p 100 Etf (OEF)

View all positions for Envestnet Asset Management

Top funds holding Avadel Pharmaceuticals

Henderson Group
BlackRock
Vanguard Group
Brandes Investment Partners
Two Seas Capital
Jeffrey L. Gendell
Polar Capital Holdings
Vivo Capital
State Street Corporation
Wealth Effects
Geode Capital Management
Tang Capital Management
Susquehanna International
Kennedy Capital Management
Citadel Advisors

View all funds holding Avadel Pharmaceuticals